Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Clindamycin Hydrochloride,Adapalene,Benzoyl Peroxide
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : IDP-126 (clindamycin 1.2%, adapalene 0.15%, benzoyl peroxide 3.1%) gel has the potential to be the first of its kind fixed dose triple combination treatment for acne vulgaris by inhibiting bacterial protein synthesis.
Brand Name : IDP-126
Molecule Type : Small molecule
Upfront Cash : Not Applicable
May 01, 2023
Lead Product(s) : Clindamycin Hydrochloride,Adapalene,Benzoyl Peroxide
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : Clindamycin hydrochloride is a bacteriostatic which inhibits bacterial protein synthesis by binding to the 23S RNA of the 50S subunit of the ribosome.
Brand Name : Cleocin-Generic
Molecule Type : Small molecule
Upfront Cash : Not Applicable
March 14, 2023
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved
Sponsor : Navamedic
Deal Size : Undisclosed
Deal Type : Agreement
Navamedic ASA Acquires Innovative Antibiotic Product for Hospital Use in The Nordic Region
Details : Clindamycin is a well-established antibiotic used in treatment of severe infections, including staphylococcal bone and joint infections, chronic sinusitis and infections of the lower respiratory tract.
Brand Name : Clindamycin-Generic
Molecule Type : Small molecule
Upfront Cash : Undisclosed
November 23, 2022
Lead Product(s) : Clindamycin Hydrochloride
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Sponsor : Navamedic
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?